We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$330M
Cap. Flow %
8.14%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155
Avg Time Held Equity + Options
4.2 quarters
Top 10 Avg Time Held Equity + Options
1.2 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.5 quarters
Top 10 Avg Time Held Equity only
1.2 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
K icon
Kellanova
K
+$269M
2
SRCL icon
Stericycle Inc
SRCL
+$141M
3
MRO icon
Marathon Oil Corporation
MRO
+$108M
4
CHX icon
ChampionX
CHX
+$103M
5
SPR icon
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN icon
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE icon
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN icon
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X icon
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CNTB icon
301
Connect Biopharma Holdings
CNTB
$57M
$725K 0.02%
510,701
– –
2022 Q2
9 quarters
IRON icon
302
Disc Medicine
IRON
$2.32B
$722K 0.02%
14,683
+1,364
+10% +$64K
2023 Q1
6 quarters
MRVL icon
303
Marvell Technology
MRVL
$239B
$721K 0.02%
10,000
-90,000
-90% -$6.22M
2023 Q2
5 quarters
VKTX icon
304
Viking Therapeutics
VKTX
$3.6B
$716K 0.02%
+11,316
New +$664K
2024 Q3
0 quarters
THRD icon
305
DELISTED
Third Harmonic Bio
THRD
$709K 0.02%
52,294
+3,043
+6% +$37.7K
2023 Q3
4 quarters
SPKL
306
DELISTED
Spark I Acquisition Corp
SPKL
$702K 0.02%
66,832
-2,159
-3% -$22.5K
2024 Q1
2 quarters
DYN icon
307
Dyne Therapeutics
DYN
$2.98B
$694K 0.02%
19,318
-13,626
-41% -$542K
2022 Q1
10 quarters
DRH icon
308
Diamondrock Hospitality Co
DRH
$2.61B
$690K 0.02%
+79,007
New +$665K
2024 Q3
0 quarters
ZS icon
309
Zscaler
ZS
$36.8B
$684K 0.02%
+4,000
New +$731K
2024 Q3
0 quarters
ARVN icon
310
Arvinas
ARVN
$487M
$675K 0.02%
27,403
-2,898
-10% -$75.7K
2023 Q1
6 quarters
ITOS icon
311
DELISTED
iTeos Therapeutics
ITOS
$673K 0.02%
65,940
+30,617
+87% +$467K
2024 Q2
1 quarter
NFE icon
312
PUT
New Fortress Energy
NFE
$24.1M
$659K 0.02%
1,022
– –
2024 Q2
1 quarter
VRNA
313
DELISTED
Verona Pharma
VRNA
$649K 0.02%
+22,541
New +$555K
2024 Q3
0 quarters
SKIL icon
314
Skillsoft
SKIL
$57M
$646K 0.02%
41,692
– –
2023 Q4
3 quarters
MIRM icon
315
Mirum Pharmaceuticals
MIRM
$5.59B
$645K 0.02%
16,538
-21,550
-57% -$860K
2023 Q2
5 quarters
XNCR icon
316
Xencor
XNCR
$1.86B
$644K 0.02%
+32,000
New +$601K
2024 Q3
0 quarters
XRX icon
317
PUT
Xerox
XRX
$356M
$623K 0.02%
278,300
– –
2021 Q2
13 quarters
NARI icon
318
DELISTED
Inari Medical, Inc. Common Stock
NARI
$623K 0.02%
+15,100
New +$725K
2024 Q3
0 quarters
NLY icon
319
Annaly Capital Management
NLY
$13.8B
$614K 0.02%
+30,591
New +$613K
2024 Q3
0 quarters
AFRM icon
320
Affirm
AFRM
$26.5B
$612K 0.02%
15,000
+500
+3% +$16.6K
2024 Q1
2 quarters
COTY icon
321
PUT
Coty
COTY
$2.56B
$606K 0.02%
1,264,500
– –
2023 Q3
4 quarters
PCVX icon
322
Vaxcyte
PCVX
$11B
$606K 0.02%
5,307
-1,000
-16% -$90.1K
2023 Q3
4 quarters
CNTX icon
323
Context Therapeutics
CNTX
$28M
$605K 0.01%
308,758
+15,000
+5% +$33.3K
2023 Q2
5 quarters
QTTB icon
324
Q32 Bio
QTTB
$260M
$590K 0.01%
13,229
+1,229
+10% +$45.2K
2024 Q2
1 quarter
ALGS icon
325
Aligos Therapeutics
ALGS
$34.5M
$581K 0.01%
67,096
+27,096
+68% +$337K
2024 Q1
2 quarters
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $330M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.